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A rat adrenal EDNA library was screened by colony hybridization using a rat cDNA fragment of type I angiotensin II rcccptoc (ATIA) previously 
isolated from the kidney. Two cDNA clones were identified, designated as ATIB, to have a nucleuilde sequence highly homologous to and yet 
distinct from ATIA. The amino acid sequcncc of ATlB consists of 359 amino acid residues and has 96% identity with ATIA. No conspicuous 
difference in the ligand binding characteristics was observed belwesn AT I A and AT I B. The mRNA for AT1 B was exptcssed in many tissues as 
is the case with ATIA, and most abundantly expressed in the adrenal glands in the SpragUC-DaWlCy rats. The exinence of two subtypes in the 
rat type I angiotensin II receptor might explain the diverse actions of angiolcnsin II in various tissues. 
Angiotensin II receptor 
1. INTRODUCTION 
Angiotensin II (AR) is a multifunctional peptide 
which elicits contractile, secretory, metabolic, growth, 
and neuronal activities in its diverse target cells [ 1,2,3]. 
The diversity in its actions has suggested the existence 
of several subtypes of the AI1 receptors. Recent intro- 
duction of new AI1 antagonists, such as Dup 753 and 
PD 123177 [4,5], have identified two major subtypes of 
AI1 receptor. While both subtypes, designated as AT1 
and AT2 receptors, bind AI1 and its peptide analogues 
with the comparable avidity, AT1 receptors have high 
affinity for Dup 753, and AT2 receptors have high affin- 
ity for PD 123117. To date, all of the known functions 
of AI1 seem to be mediated through the AT1 receptor, 
and the function of the AT2 receptor remains to be 
determined [4,5], which consequently suggests the ex- 
istence of subtypes in the type I receptors. 
Recently, we and others have isolated a bovine [6] and 
a rat [7,8] cDNA for the AT1 receptor. The cloned AT1 
receptors have the typical features of G protein coupled 
receptors, and are linked to phosphoinositide-specific 
phospholipase C. Southern blotting analysis of the rat 
genome using the cloned rat cDNA for AT1 receptor 
has suggested the existence of another closely related 
sequence (data not shown). Restriction enzyme map- 
ping of the polymerase chain reaction (PCR) products 
from various tissues synthesized by the primers corre- 
sponding to the cloned rat cDNA for ATL, has 
suggested the existence of a closely related sequence 
expressed in the rat adrenal (data not shown). In this 
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communication, isolation and characterization of a 
cDNA for a subtype of the rat ATI receptor from the 
adrenal is reported. 
2. MATERIALS AND METHODS 
2. I. cDNA ctorriig 
A rat adrenal cDNA library was prepared using a Superscript 
cDNA synthesis kit (Gibco-BRL. Gaithersburg. MD). The syn- 
thesized cDNAs whose sizes were more than 2 kb were selected by 
agarose gel clectrophoresis and were ligated to pSPORT I (Gibco- 
BRL), and 30,000 colonies were screened by colony hybridization 
using a &al-SucI fragment of the rat cDNA for the AT1 receptor [8] 
which covered almost all of the coding region. The hybridtition was 
done in 35% formamide, 6xSSC (0.90 M NaCI, 0.09 M sodium 
citmte), 50 mM NaH,P0,/NalHP04 (pH 7.0), and 1% sodium do- 
decyl sulfate (SDS) at 42°C for 12 h. The filters were washed in 2&C 
containing 1% SDS at 60°C. 
Sequence analysis was done on both strands directly from double 
stranded plasmids using a Scqucnasc sequence kit (United States 
Biochemical Corp., Clcaveland, OH) and E.-coIlllMung Bean nrrclease 
deletion kit (Stratagrcne, La Jolla, CA). 
2.2, RNA blot fg~bridkatfon rrnu@is 
Total RNA and poly(A)* RNA were isolated as described prcvi- 
ously [9]. RNA hybridization analysts wcredone in a solution contain- 
ing 50% formamide, 6xSSC, 50 mM sodium phosphate buffer (pH= 
7-O), 1% SDS at 42.O”C for 12 II. The filters were washed twice at 
65.0°C in a solution containing l&SC and 1% SDS. 
2.38 DNA trur@ction 
The cloned cDNA fragment (whole length) was inserlcd into a 
mammalian expression vector pcDNA I (InVitrogen, San Diego, CA). 
DNA transfection to Cos 7 fells was performed as described previ- 
ously [6,8] using an electroporation system (Bio Rad, La John, CA). 
Three days after transfection, the cells were subjected to ‘=I-an&- 
tcnsin 11 binding assay, The receptor binding assay was done aa prcvi- 
ously described [8, IO]. 
2.4. Pofymrrusc cfruitr reaction 
To assess the ratio of the expression levels of ATI A mRNA to that 
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of ATlB mRNA, the polymcrasu chain reaction (PCR) method was 
employed. The primers used were as follows: 
5’.sense primer = YGGAAACAGCITGGTGGTG-3’ (133-150) 
3’-antisense primer = 5’-GCACAATCGCCATAATTATCC-3’ 
(739-719) 
4--- 
Fig. 1. Nucleotidc sequence of ATIB. (A) Nucleotidc and deduced 
amino acid sequence of ATI 8, The deduced amino acid sequence is
shown above the nuclcotide sequence, and the putative transmcm. 
branc domains I-VII are indicated above the amino acid sequence. 
Three possible N-glycosylation sites are indicated by asterisks; poten- 
tial phasphorylation sites are indicated by dots. The nucleotide se- 
quence of the coding region of ATIA is shown below that of ATIB. 
Only the sequences of the different nucleotides are shown. The undcr- 
lined regions correspond to the primers’ sequences used in the PCR 
analysis (Fig. 3). (B) Restriction map of the 2.3 kb clone. The 5’ %/I 
site and 3’ Nor1 site are the insertion sites of the cDNA into pSPORT 
I. The thick line indicates the coding region. 
These primers corresponded to the regions where no sequence di- 
vergence was noted between ATIA and ATIB. Ten-to-twenty micro- 
grams of total RNA from various tissues were reverse-transcribed 
using random primers as a primer, and the resultant cDNA mixtures 
were amplified by PCR [8] using the two primers described above. The 
reaction protile included 30-35 cycles of denatureration at 95°C for 
30 s, annealing at 54°C for 60 s, and polymerization at 72°C for 90 
s. Contamination of genomic DNA in the sample RNAs was neglected 
by subjecting the RNAs directly to PCR amplification in which no 
significant product was synthesized, The DNA fragment synthesized 
from ATIA mRNA should have seven HueliI sites, and that from 
ATI B should have four HeuIII sites. The digested PCR products were 
electrophoresed on a 6% polyacrylamide gel. A trace amount of 
[a’?P]dCTP was included in the PCR reaction mixture for autoradiog- 
raphy. The whole cDNA fragment of ATIA and ATlB were inserted 
into pBluescript KS(+) (Stratagene). Synthetic RNA copies of ATIA 
and ATI B mRNA were synthesized using T7 RNA polymerase ac- 
cording to the manufacturer’s recommended method after linearizam 
tion of the template plasmids. 
Male Sprague-Dawlcy rats, spontaneously hypertensive rats, and 
Wistar-Kyoto rats were obtained from Taconic Farms (Germantown, 
100 
50 
0 
Fig. 2. Binding characteristics of ATIB. Displacement of %labelled 
angiotcnsin I1 (0.2 nM) by unlabelled angiotensin II (m), Dup 753 (o), 
angiotensin II1 (a), and Exp 655 (*). Each point represenls a mean 
value of triplicate xperiments. 
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5 RESULTS AND DISCUSSION 
From the 30,000 clones screened, two clones were 
isolated which hybridized to the rat AT1 cDNA frag- 
ment. The insert size of one clone was 2.3 kb and that 
of the other was 2.2 kb. These two clones were identified 
1 2 3 4 5 6 7 8 
A 
I3 12345670910 
to correspond to the same mRNA based on the nu- 
cleotide sequence analyses, and were revealed to be dis- 
tinct from the cDNA for the rat ATI receptor previ- 
ously cloned. Figure 1 shows the nucleotide sequence of 
the 2.3 kb cDNA, and the deduced amino acid se- 
quence. The AT1 receptor which was isolated previ- 
ously from the rat kidney is designated ATIA, and the 
EDNA which was isolated in the present study is de- 
signated as ATlB in this communication. The amino 
acid sequence of ATIB also consists of 359 amino acid 
residues, has 96% sequence identity with ATM, and 
shares features commonly found in other G protein 
soupled receptors. No significant sequence homology 
was noted in the untranslated region shown in the Fig. 
1 between ATlA and ATlB. 
The positions of the putative transmembrane 
domains I-VII are tentatively assigned on the basis of 
a hydropathy profile and a sequence comparison with 
other G protein coupled receptors. There are several 
potential sites for post-translational modification in 
ATIB which include three cosensus sites for N-gly- 
cosylation in extracellular loops, one of which is in the 
N-terminus preceeding the first transmembrane domain 
and the other two arc in the third extracellular loop. 
One cysteine residue is present in each of the four ex- 
tracellular loops which would form two disulfide 
bridges essential for ligand binding [l I]. Several serine 
1234567 
Fig. 3. Expression of the mRNA for ATI B. (A) Nothcrn blot analysis of AT1 B. Two micrograms of the poly(A)’ RNA from kidney (lane I), brain 
(2), ventricle of the heart (3) adrenal (4), spleen (S), liver (6), ileum (7), and fetal skin (8) were used in the analysis. All the sample RNAs in this 
experiment were obntined from Sprague-Dawlry rats. The upper panel was obtained by using the whole cDNA fragment of the ATlB as a probe, 
and the lower panel was obtained by using the SufLViuIII fragment (see Fig. 113) as a probe. The position of the 18s ribosomal RNA is marked 
in the left side. (B) Polymcrase chain reaction (PCR) analysis of the expression of AT1 B mRNA. f?l&r pmei: the RNAscontaining 10 pgofsynthctic 
ATlB RNA (B-RNA) (lane I), 8 pg of B-RNA and 2 pg of synthetic ATlA RNA (A-RNA) (lane 2), 6.67 pg of B-RNA and 3.33 pg of A.RNA 
(lanc3). 5 pg of B-RNA and A-RNA (lane 4), 3.33 pp of B-RNA and 6.67 pg of A-RNA (lane S), 2 pg of B-RNA and 8 pg of A-RNA (Inne 6), 
and 10 pg of A-RNA (lane 7) wcrc reverse-transcribed, and the resultant cDNA mixtures were amplified. The PCR products were ethanol 
preoipitated and then digested with HaelK. The DNA fragment originating from B-RNA should give 263 bp. 103 bp. 9.5 bp, 96 bp, and 54 bp 
fragments, while that from ATIA should give 151 bp, 1 I2 bp, 95 bp, 69 bp, 54 bp. 48 bp, 42 bp, and 34 bp. Please nom that the 39 bp fmgmcnl 
is an artifact of primers’ dimer which is indicated on the right side. L/r purl: ten micrograms of the total RNA from the adrenals ofSD mh (lane 
l), livers of SD rats (?), livers of WKf (W) rals (3). livers of S HR (S) rxs Q?), brains of W rats (5). brains of $ rats (6), kidneys of W rats (7). 
kidneys of S rats (8) adrenals of W rats (9), and adrenals of S mts (10) were revcrse~transcribcd, an  the resultant cDNA mixtures were amplified 
by PCR. The PCR products were digested with Huulll restriction enzyme. Three 20.week-old SHR and WKY rats wcrc used to isolate the sample 
RNAs. 
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and threonine residues exist in the second and C-ter- 
minal cytoplasmic domain for possible regulatory phos- 
phorylation [12,133. Other notable features include the 
highly hydrophilic N-terminal sequence, and the short 
third cytoplasmic loop. All these features are shared in 
common with ATlA. 
The ligand binding characteristics for the ATI I3 was 
determined by expressing the cloned cDNA in Cos 7 
cells. The binding of ‘%A11 to the transfected Cos 7 
cells was saturable with a dissociation constant (Kn) of 
2.3 nM, which is comparable to that of ATlA (I.6 
nM-1.9 nM) [7,S]. No significant binding was observed 
in the mock-transfected Cos 7 cells. A displacement 
experiment (Fig. 2) of “51-AII binding indicated that 
DUP 753 (type I specific antagonist) is by far a more 
potent inhibitor than EXP 655 (type II antagonist), 
which indicated that ATlB has also type I character. 
Expression of AT1 I3 mRNA in various tissues was 
investigated by Nothern blotting (Fig. 3A). Because the 
untranslated region of the ATlB has no significant se- 
quence similarity to ATIA, the fragment (Sal I-Nlr( III) 
containing the 5’ untranslated region was used as a 
probe. As shown in Fig. 3A (lower panel) AT1 B mRNA 
was detected in the adrenal, and slightly in the kidney. 
The same pattern was obtained when using a fragment 
from the 3’ untranslated region (data not shown). In 
contrast to the lower panel, the upper panel shows a 
Nothern blot analysis probed with the whole cDNA of 
ATlB in which prominent signals were obtained in the 
kidney and the liver. The polymerase chain reaction 
method was employed to assess the ratios of the expres- 
sion of ATI A mRNA to that of ATlB mRNA in vari- 
ous tissues. The two primers used corresponded to the 
regions where no nucleotide sequence difference exist 
between ATlA and ATIB. The synthesized DNA frag- 
ment from ATlA should have seven !1&11 sites, and 
that from ATlB should have four k1&11 sites. As 
shown in Fig. 3B (right panel) the molecular atios of 
the mRNA for ATlA to that for ATlB can be roughly 
estimated by digesting the PCR products with HueIII. 
Please note that the mRNAs in the Nothern blot analy- 
sis (Fig. 3A) were obtained from Sprague-Dawley rats, 
and most of the mRNAs used in the PCR analysis were 
obtained from SHR and WKY (lane 3-10). Although 
the molecular atios of ATlA mRNA to AT1 B mRNA 
vary between tissues and strains (SD versus SHR or 
WKY), the mRNA for ATlB is also expressed in as 
many tissues as that for AT1 A. 
The presence of heterogeneity among the AI1 re- 
ceptor population has been suggested from the observa- 
tion that AI1 elicited diverse responses in various tis- 
sues, although most AI1 receptors in various tissues 
seem to possess imilar binding affinities and specifici- 
ties for AI1 and its peptide analogs. For instance, the 
AI1 receptors have been reported to be linked via G 
proteins to phospholipase C [ 141, adenylate cyclase [ 151 
and calcium channels [16]. Whether the two subtypes of 
the type I AI1 receptors have different functional pro- 
perties, such as coupling to different G proteins [17], 
remains to be determined. 
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